<unk>  is a aminoquinoline antimalarial that is FDA approved for the treatment of for the suppressive treatment and for acute attacks of malaria due to P. vivax, P. malariae, P. ovale, and susceptible strains of P. falciparum. The drug is also indicated for the treatment of extraintestinal amebiasis.. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include cardiovascular, dermatological, immunological, neurological and ophthalmological (see Adverse Reactions section).
Chloroquine
Debrisoquine
Flumequine
Amodiaquine
Artemether
Primaquine phosphate
Tafenoquine
Piperaquine